Ebru Şancı

4PUBLICATIONS
22CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Biogeography and phylogeographyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 06, 2026
Zafirlukast Exacerbates Behavioral Seizure Activity and Blood-Brain Barrier Disruption Despite Modestly Reducing Neuronal Injury Markers in a PTZ-Induced Early Epileptogenesis Mouse Model.

|Feb 27, 2026
CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and In Vivo Evaluation.

Cem Güler, S Sacide Gelen, Ebru Şancı

|Jan 21, 2026
Mitochondrial Dynamics-Related Gene Regulation by Epigenetic Suppression of GCN5 Exerts Neuroprotective Effects in Rotenone-Induced Parkinson's Disease Model.

Gökçe Ceren Kuşçu, Ezgi Tut, Çevik Gürel

|Feb 13, 2024
Oxidative stress and inflammatory markers in streptozotocin-induced acute and subacute toxicity response.

Ebru Şancı, Çinel Köksal Karayıldırım, Melih Dağdeviren

Pageof 1

Frequent Collaborators

4 joint publications

Aylin Buhur

4 joint publications

Nefise Ulku Karabay Yavasoglu

4 joint publications

Altug Yavasoglu

2 joint publications

Cem Güler